Peptide macromolecular complexes

• US 4,275,000 A
• Filed: 08/21/1978
• Issued: 06/23/1981
• Est. Priority Date: 08/22/1977
• Status: Expired due to Term

• Current Assignee: British Technology Group Ltd. (Boston Scientific Corporation)
• Original Assignee: National Research Development Corporation
• Inventors: Ross, Walter C. J.
• Primary Examiner(s): SCHAIN, HOWARD
• Application Number:
  US05/934,710
• Time in Patent Office: 1,037 Days
• Field of Search: 260/112 R, 260/121, 260/112.5 R, 260/112 B, 260/112.5, 424/85, 424/88, 424/92, 424/121, 424/85, 424/177, 195/63, 195/68, 435/188
• US Class Current: 530/359
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61K 47/6889 Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
• CPC Class Codes: C07K 1/1072 by covalent attachment of residues or functional groups
• CPC Class Codes: C12N 11/06 attached to the carrier via a bridging agent
• CPC Class Codes: G01N 33/531 Production of immunochemical test materials
• CPC Class Codes: Y10S 530/825 Bacteria
• CPC Class Codes: Y10S 530/866 involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Abstract

Macromolecular complexes which comprise a first and a second macromolecular moiety joined by a link derived from a linking agent having two or more reactive groups, one of these reactive groups being an activated acyl group, an isocyanate, an isothiocyanate, an iminoether, an iminothioether or an activated halogen atom attached to an aromatic ring and being capable of reacting with one of the macromolecules from which the macromolecular moieties are derived, under conditions where the remaining reactive group, or groups which is or are each an aziridine ring, an aryl azido group or a halogen atom in an α-position relative to a carbonyl group or two carbon atoms removed from a heteroatom carrying a lone pair of electrons, is or are substantially unreactive.

Methods are provided for making the complexes and so are uses for the complexes. Pharmaceutical formulations containing the complex as are provided.

Claims

1. A macromolecular complex which comprises a first and a second peptide macromolecular moiety, joined by a link derived from a linking agent having two or more reactive groups, one of these reactive groups being selected from the group consisting of activated acyl groups, isocyanates, isothiocyanates, iminoethers, iminothioethers and activated halogen atoms attached to aromatic rings and being capable of reacting with one of the macromolecules from which the macromolecular moieties are derived, under conditions where the remaining reactive group or groups which is or are each selected from the group consisting of aziridine rings, aryl azido groups and halogen atoms in an α

-position relative to a carbonyl group or two carbon atoms removed from a hetero-atom carrying a lone pair of electrons, is or are substantially unreactive.

2. A complex according to claim 1 in which the first and second macromolecules are each selected from the group consisting of antigens, antibodies, enzymes, lipoproteins, serum albumins, toxins and toxoids.

3. A complex according to claim 2 in which either (a) one of the macromolecules is a diphtheria toxin and the other is an antibody or (b) one of the macromolecules is an antilymphocytic globulin and the other is a toxin.

20. A macromolecular complex according to claim 1 wherein group B is selected from the group consisting of aziridine rings and halogen atoms that are two carbon atoms from a heteroatom carrying a lone pair of electrons.

21. A macromolecular complex according to claim 1 wherein Group B comprises ##STR12##

4. A macromolecular complex comprising a first and a second peptide macromolecular moiety, joined by a link derived from a linking agent having two or more reactive groups, in which the link is a radical derived from a compound selected from the group consisting of acyl derivatives of chlorambucil, of 4-(2-chloroethyl)amino benzene butanoic acid, of 2,4-dinitro-5-aziridinylbenzoic acid, and of 5-azido-2,4-dinitrobenzoic acid.

5. A method of linking peptide macromolecules which comprises:

(a) reacting a first peptide macromolecule M¹ with a linking agent A--L--B in which A is a first reactive group which is selected from the group consisting of activated acyl groups, isocyanates, isothiocyanates, iminoethers, iminothioethers, activated halogen atoms attached to aromatic rings, L is a linking group joining A and B, and B is a second reactive group or further reactive groups which is or are each selected from the group consisting of aziridine rings, aryl azido groups and halogen atoms in an α

-position relative to a carbonyl group or two carbon atoms from a hetero atom carrying a lone pair of electrons, under reaction conditions where the group A is reactive but B is (are) not reactive to give an intermediate M¹ --L'"'"'--B in which L'"'"' is the same as L or is derived from L and A

(b) reacting the intermediate M¹ --L'"'"'--B with a second peptide macromolecule M² under reaction conditions where the group B is (are) reactive to give a complex M¹ --L"--M² in which L" is the same as L'"'"' or is derived from L'"'"' and B; and

(c) isolating the complex produced.

6. A method according to claim 5 in which the activated acyl group is selected from the group consisting of acyl halides, acyl anhydrides, acylazides and activated esters.

7. A method according to claim 6 in which the acyl halide, acyl anhydride, acylazide or activated ester is selected from the group consisting of such derivatives of chlorambucil, of 4-(2-chloroethyl)aminobenzene butanoic acid, of 2,4-dinitro-5-aziridinylbenzoic acid, and of 5-azido-2,4-dinitrobenzoic acid.

8. A method according to claim 7 in which the acyl group of the acyl derivative of a compound selected from the group consisting of chlorambucil and 4-(2-chloroethyl)aminobenzene butanoic acid reacts with an amino group in macromolecule M¹ at less than 10°

C. and the chloroethyl group reacts with a carboxyl or amino group in macromolecule M² at 25°

to 30°

C.

9. A method according to claim 7 in which the acyl group of the acyl derivative of a compound selected from the group consisting of chlorambucil and of 4-(2-chloroethyl)aminobenzene butanoic acid reacts, in the presence of a relatively high concentration of halide ions, with an amino group in macromolecule M¹ and the chloroethyl group reacts, in the presence of a relatively lower concentration of halide ions, with a carboxyl or amino group in macromolecule M².

10. A method according to claim 7 in which the acyl derivative of 2,4-dinitro-5-aziridinylbenzoic acid reacts with an amino group in macromolecule M¹ at alkaline or neutral pH and the aziridine ring reacts with a carboxyl group in macromolecule M² at acidic pH.

11. A method according to claim 5 in which the first and second macromolecules are each selected from the group consisting of antigens, antibodies, enzymes, lipoproteins, serum albumins, toxins and toxoids.

12. A method according to claim 11 in which either (a) one of the macromolecules is a diphtheria toxin and the other is an antibody or (b) one of the macromolecules is an anti-lymphocytic globulin and the other is a toxin.

13. A method according to claim 5 in which the linking agent molecule contains only one B group.

14. A method according to claim 5 in which the intermediate M¹ --L'"'"'--B is isolated and purified before step (b).

16. A method according to claim 5 in which one of the macromolecules is an antibody and the other is an enzyme.

17. A method according to claim 5 in which, following step (a), the reaction conditions are adjusted in temperature or pH so as to cause group B to react under the new conditions with macromolecule M², although group B had not reacted with macromolecule M¹ under the previous conditions.

18. A method according to claim 5 wherein group B is selected from the group consisting of aziridine rings and halogen atoms that are two carbon atoms from a heteroatom carrying a lone pair of electrons.

19. A method according to claim 5 wherein group B comprises ##STR11##

15. A macromolecular complex which comprises a first antibody macromolecular moiety and a second enzyme macromolecular moiety joined by a link derived from a linking agent having two or more reactive groups, one of these reactive groups being selected from the group consisting of activated acyl groups, isocyanates, isothiocyanates, iminoethers, iminothioethers and activated halogen atoms attached to aromatic rings and being capable of reacting with one of the macromolecules from which the macromolecular moieties are derived, under conditions where the remaining reactive group or groups which is or are each selected from the groups consisting of aziridine rings, aryl azido groups and halogen atoms in an α

-position relative to a carbonyl group or two carbon atoms removed from a heteroatom carrying a lone pair of electrons, is or are substantially unreactive.

22. A macromolecular complex which comprises a peptide macromolecular moiety and a phospholipid macromolecular moiety joined by a link derived from a linking agent having two or more reactive groups, one of these reactive groups being selected from the group consisting of activated acyl groups, isocyanates, isothiocyanates, iminoethers, iminothioethers and activated halogen atoms attached to aromatic rings and being capable of reacting with one of the macromolecules from which the macromolecular moieties are derived, under conditions where the remaining reactive group or groups which is or are each selected from the group consisting of aziridine rings, aryl azido groups and halogen atoms in an α

-position relative to a carbonyl group or two carbon atoms removed from a heteroatom carrying a lone pair of electrons is or are substantially unreactive.